Neumora Therapeutics (NMRA) Shares Outstanding (2022 - 2026)

Neumora Therapeutics' Shares Outstanding history runs 5 years deep, the most recent figure standing at $182.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 12.62% year-over-year to $182.2 million; the TTM figure through Mar 2026 stood at $182.2 million (up 12.62% YoY), while the FY2025 annual figure was $4.5 million, down 97.22% from the prior year.
• Shares Outstanding was $182.2 million for Q1 2026 at Neumora Therapeutics, up from $4.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $182.2 million in Q1 2026 to a low of $4.5 million in Q4 2025.
• Historically, Shares Outstanding has averaged $117.1 million across 5 years, with a median of $159.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding jumped 387.33% in 2024, then sank 97.22% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $32.6 million in 2022, then surged by 387.04% to $158.8 million in 2023, then increased by 1.81% to $161.7 million in 2024, then tumbled by 97.22% to $4.5 million in 2025, then soared by 3946.19% to $182.2 million in 2026.
• The last three Shares Outstanding figures came in at $182.2 million (Q1 2026), $4.5 million (Q4 2025), and $161.9 million (Q3 2025), per Business Quant data.